83 The prognostic significance of peripheral blood biomarkers in patients with advanced non-small cell lung cancer treated with pembrolizumab: a clinical study

83 The prognostic significance of peripheral blood biomarkers in patients with advanced non-small cell lung cancer treated with pembrolizumab: a clinical study

Bibliographic Details
Main Authors:	Kira MacDougall, Muhammad Niazi, Jeff Hosry, Sylvester Homsy, Alexander Bershadskiy
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
by: Michael M. Boyiadzis, et al.
Published: (2018-05-01)

Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study
by: Satoru Taguchi, et al.
Published: (2021-08-01)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
by: Sarah Richtmann, et al.
Published: (2019-05-01)

Validity, Reliability, and Sensitivity of the d13C Added Sugar Biomarker in Children and Adolescents
by: MacDougall, Carly Rimmer
Published: (2017)

Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer
by: Junqing Gan, et al.
Published: (2020-12-01)

Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer
by: Junqing Gan, et al.
Published: (2021-04-01)

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
by: Zuyi Ma, et al.
Published: (2021-01-01)

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
by: Ya Chen, et al.
Published: (2021-04-01)

Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
by: Andrés F. Cardona, et al.
Published: (2021-03-01)

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
by: Kira MacDougall, et al.
Published: (2020-04-01)

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab
by: Gil Awada, et al.
Published: (2021-01-01)

Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles
by: Moira Graves, et al.
Published: (2019-05-01)

Perforation of small intestinal metastasis of lung adenocarcinoma treated with pembrolizumab: a case report
by: Shoki Sato, et al.
Published: (2019-10-01)

A case of large-cell lung carcinoma successfully treated with pembrolizumab but complicated with cholangitis
by: Ryunosuke Ooi, et al.
Published: (2020-01-01)

Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis
by: Akio Osa, et al.
Published: (2019-11-01)

Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report
by: Teppei Sugano, et al.
Published: (2019-02-01)

Toxic epidermal necrolysis as a complication of pembrolizumab treatment in a lung cancer patient
by: Reika Aoyama, et al.
Published: (2021-04-01)

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer
by: Anello Marcello Poma, et al.
Published: (2021-07-01)

Strategic timing of commercial-scale tidal energy investment
by: S. MacDougall
Published: (2018-09-01)

Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab
by: Marion Fradet, et al.
Published: (2019-10-01)

Multiple Brain Pseudoprogression in a Patient With NSCLC Treated With Pembrolizumab
by: Laura Moliner, MD, et al.
Published: (2020-09-01)

Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1
by: Zaoqu Liu, et al.
Published: (2021-04-01)

Sarcoid‐like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab
by: Shinkichi Takamori, et al.
Published: (2021-07-01)

Lung adenocarcinoma initially presenting as Trousseau's syndrome treated successfully with pembrolizumab: A case report
by: Yuta Nakano, et al.
Published: (2021-02-01)

Prognostic significance of inflammatory biomarkers in diabetic and non-diabetic patients with STEMI, treated with primary percutaneous coronary intervention
by: Milić Veljko, et al.
Published: (2019-01-01)

Methods of Analysis For Linear Systems with Time Varying Parameters.
by: MacDougall, Donald Gerrad, et al.
Published: (2012)

A case of multi-agent drug resistant choriocarcinoma treated with Pembrolizumab
by: Jennifer A. Goldfarb, et al.
Published: (2020-05-01)

Development of drug-induced arthritis in a glioblastoma patient treated with pembrolizumab
by: Casey B Brown, et al.
Published: (2018-01-01)

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
by: Matthew D. Tucker, et al.
Published: (2019-08-01)

Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma
by: Michelle A. McNally, BSN, et al.
Published: (2021-04-01)

The potential prognostic roles of biomarker expression in peripheral blood for non-small cell lung cancer
by: Yi-Ying Wu, et al.
Published: (2016)

PROGNOSTIC SIGNIFICANCE OF BIOMARKERS IN ORAL SQUAMOUS CELL CARCINOMA. REVIEW
by: A. V. Ignatova, et al.
Published: (2015-04-01)

Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma
by: Meng X, et al.
Published: (2021-09-01)

Prognostic Significance of Peripheral T‐Cell Subsets in Laryngeal Squamous Cell Carcinoma
by: Filippo Marchi, et al.
Published: (2019-10-01)

Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy
by: Jhen-Bin Lin, et al.
Published: (2019-05-01)

COINING FOR A FACTION: COMPETING DEPICTIONS OF FOREIGN PEOPLES AND PLACES ON ROMAN COINAGE IN CIVIL WAR HISPANIA (RRC 468, RRC 469, RRC 470)
by: Ellen MacDougall
Published: (2020-07-01)

Alasdair Raffe, The Culture of Controversy: Religious Arguments in Scotland, 1660-1714. Woodbridge: The Boydell Press, 2012. Pp. 310. ISBN: 9781843837299. $124.00 CAD.
by: Jamie MacDougall
Published: (2015-08-01)

Refugees from Inside the System: Iraqi Divorcees in Jordan
by: Susan MacDougall
Published: (2012-11-01)

Research-Teaching Linkages: Beyond the Divide in Undergraduate Medicine
by: Margaret MacDougall
Published: (2012-08-01)

Cinema Transcultural.
by: David MacDougall.
Published: (2009-07-01)

Cannot write session to /tmp/vufind_sessions/sess_mprfpis9b4npg4houj0thq9uo1